|
|
||||||||
/
vascular smooth muscle cells
1 Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania 15261; and 2 GenVec Inc., Gaithersburg, Maryland 20878
The functional
role of p53 in nitric oxide (NO)-mediated vascular smooth muscle cell
(VSMC) apoptosis remains unknown. In this study, VSMC from
p53
/
and p53+/+ murine aortas were exposed
to exogenous or endogenous sources of NO. Unexpectedly,
p53
/
VSMC were much more sensitive to the
proapoptotic effects of NO than were p53+/+ VSMC.
Furthermore, this paradox appeared to be specific to NO, because other
proapoptotic agents did not demonstrate this differential effect on
p53
/
cells. NO-induced apoptosis in
p53
/
VSMC occurred independently of cGMP generation.
However, mitogen-activated protein kinase (MAPK) pathways appeared to
play a significant role. Treatment of the p53
/
VSMC
with S-nitroso-N-acetylpenicillamine resulted in
a marked activation of p38 MAPK and, to a lesser extent, of c-Jun
NH2-terminal kinase, mitogen-activated protein kinase
kinase (MEK) 1/2, and p42/44 (extracellular signal-regulated kinase,
ERK). Furthermore, basal activity of the MEK-p42/44 (ERK)
pathway was increased in the p53+/+ VSMC. Inhibition of p38
MAPK with SB-203580 or of MEK1/2 with PD-98059 blocked NO-induced
apoptosis. Therefore, p53 may protect VSMC against NO-mediated
apoptosis, in part, through differential regulation of MAPK pathways.
mitogen-activated protein kinase; guanosine 3',5'-cyclic monophosphate, p38; c-Jun NH2-terminal kinase; p42/44
This article has been cited by other articles:
![]() |
S. S. Ahanchi, V. N. Varu, N. D. Tsihlis, J. Martinez, C. G. Pearce, M. R. Kapadia, Q. Jiang, J. E. Saavedra, L. K. Keefer, J. A. Hrabie, et al. Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2388 - H2398. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. McLaughlin and B. Demple Nitric Oxide-Induced Apoptosis in Lymphoblastoid and Fibroblast Cells Dependent on the Phosphorylation and Activation of p53 Cancer Res., July 15, 2005; 65(14): 6097 - 6104. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mizuno, M. Kadowaki, Y. Demura, S. Ameshima, I. Miyamori, and T. Ishizaki p42/44 Mitogen-Activated Protein Kinase Regulated by p53 and Nitric Oxide in Human Pulmonary Arterial Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 184 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tian, J. Liu, P. B. Bitterman, and R. J. Bache Mechanisms of cytokine induced NO-mediated cardiac fibroblast apoptosis Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1958 - H1967. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |